Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Ursolic acid and resveratrol synergize with chloroquine to reduce melanoma cell viability.
Compounds are well-tolerated in humans.
»
02/04/15
LINE-1 hypermethylation in peripheral blood of cutaneous melanoma patients is associated with metastasis.
LINE-1 hypermethylation in peripheral blood of melanoma patients is a potential epigenetic biomarker.
»
02/04/15
Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells.
mTOR inhibition enhances GAS5 transcript levels in certain prostate cancer cell lines.
»
10/09/14
Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer.
SPINK1 expression was observed exclusively in a subgroup of cancers that expressed TFF3.
»
08/28/14
Identification of microRNAs and target genes involved in serous ovarian carcinoma and their influence on survival.
In SOC tissue, expression of miR-200a, miR-93, miR-146a, and miR-18a were up-regulated.
»
01/06/15
BANF1 Is Downregulated by IRF1-Regulated MicroRNA-203 in Cervical Cancer.
Inhibitory effect of miR-203 on the cancer cells is partially mediated by downregulating its target, BANF1.
»
02/04/15
Expression of TRF2 and its prognostic relevance in advanced stage cervical cancer patients.
High TRF2 expression levels had a positive impact in five year survival rate of stage IIIB-IVA patients (P = 0.04).
»
07/07/14
Inhibitory effect of maple syrup on the cell growth and invasion of human colorectal cancer cells.
Administration of maple syrup clearly inhibited AKT phosphorylation.
»
10/13/14
Beclin 1 regulates growth factor receptor signaling in breast cancer.
Novel role for beclin 1 in regulating growth factor signaling.
»
10/12/14
Targeting of Runx2 by miRNA-135 and miRNA-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease.
Aberrant expression of Runx2 in aggressive tumor cells is related to the loss of specific Runx2-targeting miRNAs.
»
01/31/15
< Prev
Next >